Envista’s third quarter results exceeded Wall Street’s expectations, with management attributing performance to broad-based growth across its core businesses and a significant margin expansion. CEO Paul Keel highlighted balanced contributions from both volume and pricing, with all major segments—orthodontics, consumables, diagnostics, and implants—delivering growth. Notably, margin improvements were supported by productivity initiatives and the Spark aligner business reaching positive operating profit for the first time. Management also credited recent product launches and increased investment in R&D and sales for fueling momentum.
Is now the time to buy NVST? Find out in our full research report (it’s free for active Edge members).
Envista (NVST) Q3 CY2025 Highlights:
- Revenue: $669.9 million vs analyst estimates of $640.2 million (11.5% year-on-year growth, 4.6% beat)
- Adjusted EPS: $0.32 vs analyst estimates of $0.28 (16% beat)
- Adjusted EBITDA: $97.1 million vs analyst estimates of $90.52 million (14.5% margin, 7.3% beat)
- Management raised its full-year Adjusted EPS guidance to $1.13 at the midpoint, a 2.3% increase
- Operating Margin: 8.6%, up from 3.5% in the same quarter last year
- Constant Currency Revenue rose 9.6% year on year (-5.3% in the same quarter last year)
- Market Capitalization: $3.31 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Envista’s Q3 Earnings Call
-
Allen Lutz (Bank of America) asked about the long-term margin trajectory for the Spark aligner business after reaching profitability. CEO Paul Keel responded that Spark’s margins should eventually reach company averages, citing ongoing cost improvements and commercial synergies.
-
Elizabeth Anderson (Evercore) questioned the impact of value-based procurement (VBP) policies in China on segment performance. Keel explained that the orthodontic VBP is progressing as expected, and a second round for implants is anticipated, but the company expects a smaller impact compared to prior cycles.
-
Jeffrey Johnson (Baird) sought clarification on core growth adjustments and inventory dynamics, particularly regarding prior buy-ahead activity in Brackets & Wires. CFO Eric Hammes confirmed that inventory effects had normalized, and underlying growth metrics were in the 5-6% range after adjustments.
-
Jonathan Block (Stifel) inquired about drivers behind double-digit consumables growth and the sustainability of share gains. Keel attributed strength to infection prevention products, DSO demand, and the relative insulation of consumables from consumer confidence swings.
-
David Saxon (Needham) questioned margin guidance versus long-term financial targets, asking if recent margin performance is a baseline for next year. Hammes said current performance aligns with the company’s multi-year growth and margin leverage framework.
Catalysts in Upcoming Quarters
Looking forward, we will closely watch (1) the pace of adoption and market penetration for new product launches such as Spark Jr. and DEXIS Imprevo IOS, (2) management’s ability to sustain margin improvements while absorbing tariff and regulatory shifts, and (3) developments in China regarding value-based procurement for implants and orthodontics. Execution on operational initiatives and further gains in key accounts, especially with DSOs and international partners, will also be important indicators of future performance.
Envista currently trades at $20.15, in line with $19.98 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free for active Edge members).
The Best Stocks for High-Quality Investors
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
